Effect of changes in lymphocyte subsets at diagnosis in acute myeloid leukemia on prognosis: association with complete remission rates and relapse free survivals

Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ et al (1990) Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75(3):555–62

Mapara MY, Kim YM, Wang SP, Bronson R, Sachs DH, Sykes M (2002) Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells. Blood 100(5):1903–1909

De Somer L, Sprangers B, Fevery S, Rutgeerts O, Lenaerts C, Boon L et al (2011) Recipient lymphocyte infusion in MHC-matched bone marrow chimeras induces a limited lymphohematopoietic host-versus-graft reactivity but a significant antileukemic effect mediated by CD8+ T cells and natural killer cells. Haematologica 96(3):424–431

Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A et al (2002) Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295(5562):2097–2100

Vidriales MB, Orfao A, López-Berges MC, González M, Hernandez JM, Ciudad J et al (1993) Lymphoid subsets in acute myeloid leukemias: increased number of cells with NK phenotype and normal T cell distribution. Ann Hematol 67(5):217–222

Le Dieu R, Taussig DC, Ramsay AG, Mitter R, Miraki-Moud F, Fatah R et al (2009) Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts. Blood 114(18):3909–3916

Behl D, Porrata LF, Markovic SN, Letendre L, Pruthi RK, Hook CC et al (2006) Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia. Leukemia 20(1):29–34

The NCCN Clinical Practice Guidelines in Oncology for Acute Myeloid Leukemia, Version 1.2022. available at following website https://www.nccn.org/patients/guidelines/content/PDF/aml-patient.pdf. Accessed 18 Jan 2023

Porrata LF, Litzow MR, Tefferi A, Letendre L, Kumar S, Geyer SM et al (2002) Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemia. Leukemia 16(7):1311–1318

Shenghui Z, Yixiang H, Jianbo W, Kang Y, Laixi B, Yan Z et al (2011) Elevated frequencies of CD4+ CD25+ CD127lo regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia. Int J Cancer 129(6):1373–1381

Williams P, Basu S, Garcia-Manero G, Hourigan CS, Oetjen KA, Cortes JE et al (2019) The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia. Cancer 125(9):1470–1481

Cheng J, Ma HZ, Zhang H (2019) Detection and analysis of T lymphocyte subsets and B lymphocytes in patients with acute leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi 27(2):327–330

Najera Chuc AE, Cervantes LA, Retiguin FP, Ojeda JV, Maldonado ER (2012) Low number of invariant NKT cells is associated with poor survival in acute myeloid leukemia. J Cancer Res Clin Oncol 138(8):1427–1432

Ma L, Cheung KC, Kishore M, Nourshargh S, Mauro C, Marelli-Berg FM (2012) CD31 Exhibits multiple roles in regulating T lymphocyte trafficking in vivo. J Immunol 189(8):4104–4111

Degli-Esposti MA, Smyth MJ (2005) Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat Rev Immunol 5(2):112–124

Park Y, Lim J, Kim S, Song I, Kwon K, Koo S et al (2018) The prognostic impact of lymphocyte subsets in newly diagnosed acute myeloid leukemia. Blood Res 53(3):198–204

Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A (1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401(6754):708–712

Liu L, Chen X, Jin HM, Zhao SS, Zhu Y, Qian SX et al (2022) The expression and function of NK cells in patients with acute myeloid leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi 30(1):49–55

Boeck CL, Amberger DC, Doraneh-Gard F, Sutanto W, Guenther T, Schmohl J et al (2017) Significance of frequencies, compositions, and/or antileukemic activity of (DC-stimulated) invariant NKT, NK and CIK cells on the outcome of patients with AML. ALL and CLL J Immunother 40(6):224–248

Jamal E, Azmy E, Ayed M, Aref S, Eisa N (2020) Clinical impact of percentage of natural killer cells and natural killer-like T cell population in acute myeloid leukemia. J Hematol 9(3):62–70

Aggarwal N, Swerdlow SH, TenEyck SP, Boyiadzis M, Felgar RE (2016) Natural killer cell (NK) subsets and NK-like T cell populations in acute myeloid leukemias and myelodysplastic syndromes. Cytometry B Clin Cytom 90(4):349–357

Alcasid M, Ma L, Gotlib JR, Arber DA, Ohgami RS (2017) The clinicopathologic significance of lymphocyte subsets in acute myeloid leukemia. Int J Lab Hematol 39(2):129–136

Chretien AS, Devillier R, Granjeaud S, Cordier C, Demerle C, Salem N et al (2021) High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome. Proc Natl Acad Sci USA 118(22):e2020459118